Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

iPRG 2013: Using RNA- Seq
iPRG 2013: Using RNA- Seq
by likets
data for Peptide and Protein Identification. ABRF ...
Switch to DRV/r + 3TC DUAL Study
Switch to DRV/r + 3TC DUAL Study
by jireh
DRV/r 800/100 + 3TC 300 QD. N = 126. N = 123. DRV/...
Switch to ATV- or ATV/r-containing regimen
Switch to ATV- or ATV/r-containing regimen
by belinda
Switch to ATV/r-. containing. . regimen. ATAZIP. ...
Phase 2 of new ARVs Fostemsavir
Phase 2 of new ARVs Fostemsavir
by conchita-marotz
, . prodrug. of . temsavir. . (attachment inhib...
Essentials for Optimal Care of HIV Patients
Essentials for Optimal Care of HIV Patients
by marina-yarberry
Evidence-Based Approaches. Simply Speaking. ®. ...
Comparison of INSTI vs INSTI
Comparison of INSTI vs INSTI
by pamella-moone
QDMRK. SPRING-2. ONCEMRK. ONCEMRK. Design. Object...
Switch to DRV/r + RPV
Switch to DRV/r + RPV
by yoshiko-marsland
PROBE . Study. PROBE Study: switch to DRV/r + RPV...
NRTI-sparing
NRTI-sparing
by liane-varnes
SPARTAN. PROGRESS. RADAR. NEAT001/ANRS 14. 3. A40...
Comparison of PI vs PI ATV vs ATV/r BMS 089
Comparison of PI vs PI ATV vs ATV/r BMS 089
by phoebe-click
LPV/r mono vs LPV/r ZDV/3TC MONARK. LPV/r QD v...
CROI Update: Best of Boston
CROI Update: Best of Boston
by triclin
p. resented by. NCATEC. March . 18, . 2014. David ...
Esophageal Cancer in Tanzania
Esophageal Cancer in Tanzania
by jalin
Katherine Van Loon, MD, MPH Assistant Clinical Pro...
Clin Lab 91020131031Clin Lab 20135910311039 Copyright ORIGIN
Clin Lab 91020131031Clin Lab 20135910311039 Copyright ORIGIN
by christina
for Hepatitis C Virus Diagnosis: Usefulness among...
Developing Objective Metrics for Fatigue Impairment
Developing Objective Metrics for Fatigue Impairment
by bella
REDAC SAS. Hilary Uyhelji, PhD. 9 March 2017. FAA ...
New and Investigational ART Drugs and Strategies
New and Investigational ART Drugs and Strategies
by elina
Judith S. Currier, MD, . MSc. Division of Infectio...
Based COVID
Based COVID
by julia
PF-07302048 BNT162 RNA--19 VaccinesProtocol C45910...
Phase 2 of new ARVs
Phase 2 of new ARVs
by mitsue-stanley
Fostemsavir. , . prodrug. of . temsavir. . (. a...
Switch to PI/r + 3TC
Switch to PI/r + 3TC
by lois-ondreau
vs. PI/r . monotherapy. Study PIVOT. Study MOBID...
Comparison of NNRTI vs NNRTI
Comparison of NNRTI vs NNRTI
by tatyana-admore
ENCORE. EFV vs RPV. ECHO-THRIVE. STAR. EFV vs ETR...
Switch to LPV/r + RAL
Switch to LPV/r + RAL
by stefany-barnette
Switch to LPV/r + RAL KITE Study KITE Study: swi...
Switch to LPV/r + RAL
Switch to LPV/r + RAL
by luanne-stotts
Switch to LPV/r + RAL KITE Study KITE Study: swi...
FACILITIES AVAILABLE AT
FACILITIES AVAILABLE AT
by josephine
CENTRAL INSTRUMENTAL FACILITY. At . Bihar Animal ...
Dolutegravir ( Tivicay )
Dolutegravir ( Tivicay )
by brown
Prepared by:. Brian R. Wood, MD. David H. Spach, M...
ClinicalTrials.gov
ClinicalTrials.gov
by lauren
Identifier: . NCT02770508 . Dual therapy based on ...
Switching to Bictegravir
Switching to Bictegravir
by emery
/. Emtricitabine. /. Tenofovir. . Alafenamide. (...
HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*
HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*
by jesse588
Mandatory criteria: . Probability based sampling. ...
Switch PI/R to ETR Etraswitch
Switch PI/R to ETR Etraswitch
by dustin869
Etraswitch. . Study. : Switch PI/r to ETR. Contin...
Maraviroc ( Selzentry ) Prepared by:
Maraviroc ( Selzentry ) Prepared by:
by amelia
David H. Spach, MD. Brian R. Wood, MD. Last Update...
Joseph J. Eron Jr, MD
Joseph J. Eron Jr, MD
by lois-ondreau
Joseph J. Eron Jr, MD Professor of Medicine Unive...
Switch to INSTI + NNRTI
Switch to INSTI + NNRTI
by giovanna-bartolotta
Switch to DTG + RPV. SWORD. . Study. Switch to C...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by cheryl-pisano
FLAMINGO. GS-236-0103. ACTG A5257. WAVES . ARIA ....
SMV 150 mg QD SOF 400 mg QD
SMV 150 mg QD SOF 400 mg QD
by alida-meadow
Randomisation. 1 : 1. 18-70 years. HCV genotype 1...
Not randomised Open-label
Not randomised Open-label
by phoebe-click
18-70 years. Naïve . or failure to. PEG-IFN RB...
Site Initiation Visit Contents
Site Initiation Visit Contents
by trish-goza
Overview . Eligibility . Identification . Groups....
Molecular Haematology 10 Mar 2011
Molecular Haematology 10 Mar 2011
by test
Alberto Catalano. email: . catalano.alberto@gmail...
Fixed-Dose Combination of
Fixed-Dose Combination of
by myesha-ticknor
Doravirine. /Lamivudine/TDF is Non-Inferior to . ...
Modifying Therapy in the Treatment-experienced Patient:
Modifying Therapy in the Treatment-experienced Patient:
by yoshiko-marsland
When should it be done?. Professor of Medicine. U...
Switch to INSTI NNRTI Switch to DTG RPV
Switch to INSTI NNRTI Switch to DTG RPV
by trish-goza
SWORD. . Study. Switch to CAB LA RPV LA IM. LA...
Comparison of NNRTI vs NNRTI
Comparison of NNRTI vs NNRTI
by lindy-dunigan
ENCORE. EFV vs RPV. ECHO-THRIVE. STAR. EFV vs ETR...
Joseph J. Eron, Jr, MD
Joseph J. Eron, Jr, MD
by karlyn-bohler
Joseph J. Eron, Jr, MD Professor of Medicine and ...
Dolutegravir monotherapy
Dolutegravir monotherapy
by alexa-scheidler
Dolutegravir monotherapy vs. dolutegravir/ abac...